Florida Cancer Specialists & Research Institute Survey Finds Cancer Patients Support COVID-19 Vaccine & Mask Mandate

A survey of more than 6,800 cancer patients conducted this month by Florida Cancer Specialists & Research Institute found that patients overwhelmingly prefer that the Florida Cancer Specialists & Research Institute physicians, nurses and staff members who provide their care are vaccinated and wear masks to reduce the spread of COVID-19 and provide a safe environment within clinics. Florida Cancer Specialists & Research Institute fielded the online survey to assess patient reaction to its recent mandate for physicians and employees to be fully vaccinated for COVID-19 by October 1, 2021, with the first dose being administered no later than August 31, 2021.

The key findings of the survey are:

• The overwhelming majority (88%) of patients said it is important for Florida Cancer Specialists & Research Institute physicians, nurses and staff to be fully vaccinated for COVID-19, with 67% saying it was ‘extremely important.’
• This same percentage (88%) of patients said it is important for their Florida Cancer Specialists & Research Institute providers to wear a mask, whether or not they are vaccinated. 50% said it was ‘extremely important;’ 12% said it was ‘not at all important.’
• Over half of patients surveyed (56%) said they would consider changing to another cancer care provider if Florida Cancer Specialists & Research Institute clinicians and staff were not vaccinated and did not wear masks.
• Patients were less likely (26%) to consider changing providers if their Florida Cancer Specialists & Research Institute providers wore masks, regardless of vaccination status.

Florida Cancer Specialists & Research Institute President & Managing Physician Lucio Gordan, MD said, “At Florida Cancer Specialists & Research Institute, we base all of our decisions on what is best for the health and safety of our specialized patient population and team members. The data and the science continue to show that the vaccine is our very best defense to prevent and reduce the spread of COVID-19.”

“Our patients have strongly affirmed that our decision to mandate vaccines and masks for our workforce is of critical importance,” said Florida Cancer Specialists & Research Institute Chief Executive Officer Nathan H. Walcker. “We remain committed to doing everything possible to keep our patients, team members and their families and our communities safe and protected.

Florida Cancer Specialists & Research Institute will require all 250 physicians and nearly 4,400 team members to be fully vaccinated for COVID-19 by October 1, 2021. Those who are exempt due to documented medical or religious reasons will undergo weekly COVID-19 testing (and be required to adhere to mask policy). Additionally, FCS is continuing rigorous protocols within its nearly 100 clinic and corporate locations that include screening, mask wearing and social distancing. Visitor restrictions remain in effect to further contain the risk of COVID-19 spread and outbreak.

About Florida Cancer Specialists & Research Institute: (FLCancer.com)

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

*Prior to approval